Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1991 Mar;50(3):191–195. doi: 10.1136/ard.50.3.191

Polymyositis/dermatomyositis: the current position.

A Urbano-Márquez 1, J Casademont 1, J M Grau 1
PMCID: PMC1004375  PMID: 2015017

Full text

PDF
191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basset-Seguin N., Roujeau J. C., Gherardi R., Guillaume J. C., Revuz J., Touraine R. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases. Arch Dermatol. 1990 May;126(5):633–637. [PubMed] [Google Scholar]
  2. Bernstein R. M., Morgan S. H., Chapman J., Bunn C. C., Mathews M. B., Turner-Warwick M., Hughes G. R. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) 1984 Jul 21;289(6438):151–152. doi: 10.1136/bmj.289.6438.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bohan A., Peter J. B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975 Feb 13;292(7):344–347. doi: 10.1056/NEJM197502132920706. [DOI] [PubMed] [Google Scholar]
  4. Botet J. C., Grau J. M., Casademont J., Urbano-Márquez A., Rozman C. Characterization of mononuclear exudates in idiopathic inflammatory myopathies. Virchows Arch A Pathol Anat Histopathol. 1988;412(4):371–374. doi: 10.1007/BF00750264. [DOI] [PubMed] [Google Scholar]
  5. Bowles N. E., Dubowitz V., Sewry C. A., Archard L. C. Dermatomyositis, polymyositis, and Coxsackie-B-virus infection. Lancet. 1987 May 2;1(8540):1004–1007. doi: 10.1016/s0140-6736(87)92271-9. [DOI] [PubMed] [Google Scholar]
  6. Calabrese L. H., Mitsumoto H., Chou S. M. Inclusion body myositis presenting as treatment-resistant polymyositis. Arthritis Rheum. 1987 Apr;30(4):397–403. doi: 10.1002/art.1780300406. [DOI] [PubMed] [Google Scholar]
  7. Carpenter S., Karpati G., Heller I., Eisen A. Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology. 1978 Jan;28(1):8–17. doi: 10.1212/wnl.28.1.8. [DOI] [PubMed] [Google Scholar]
  8. Carpenter S., Karpati G. The major inflammatory myopathies of unknown cause. Pathol Annu. 1981;16(Pt 2):205–237. [PubMed] [Google Scholar]
  9. Casademont Pou J., Grau Junyent J. M., Pou Serradell A., Urbano-Márquez A. Miositis con cuerpos de inclusión: una variedad poco conocida de miopatía inflamatoria idiopática. Med Clin (Barc) 1989 Jun 24;93(4):121–124. [PubMed] [Google Scholar]
  10. Casademont J., Grau J. M., Estruch R., Pedro-Botet J. C., Urbano-Márquez A. Relationship between capillary and muscle damage in dermatomyositis. Int J Dermatol. 1990 Mar;29(2):117–120. doi: 10.1111/j.1365-4362.1990.tb04081.x. [DOI] [PubMed] [Google Scholar]
  11. Chad D., Good P., Adelman L., Bradley W. G., Mills J. Inclusion body myositis associated with Sjögren's syndrome. Arch Neurol. 1982 Mar;39(3):186–188. doi: 10.1001/archneur.1982.00510150056014. [DOI] [PubMed] [Google Scholar]
  12. Christensen M. L., Pachman L. M., Schneiderman R., Patel D. C., Friedman J. M. Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum. 1986 Nov;29(11):1365–1370. doi: 10.1002/art.1780291109. [DOI] [PubMed] [Google Scholar]
  13. Cole A. J., Kuzniecky R., Karpati G., Carpenter S., Andermann E., Andermann F. Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome. Brain. 1988 Oct;111(Pt 5):1025–1037. doi: 10.1093/brain/111.5.1025. [DOI] [PubMed] [Google Scholar]
  14. Cox N. H., Lawrence C. M., Langtry J. A., Ive F. A. Dermatomyositis. Disease associations and an evaluation of screening investigations for malignancy. Arch Dermatol. 1990 Jan;126(1):61–65. doi: 10.1001/archderm.126.1.61. [DOI] [PubMed] [Google Scholar]
  15. Dalakas M. C., Illa I., Pezeshkpour G. H., Laukaitis J. P., Cohen B., Griffin J. L. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med. 1990 Apr 19;322(16):1098–1105. doi: 10.1056/NEJM199004193221602. [DOI] [PubMed] [Google Scholar]
  16. De Visser M., Emslie-Smith A. M., Engel A. G. Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle. J Neurol Sci. 1989 Dec;94(1-3):181–192. doi: 10.1016/0022-510x(89)90228-1. [DOI] [PubMed] [Google Scholar]
  17. Dickey B. F., Myers A. R. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum. 1984 Aug;14(1):60–76. doi: 10.1016/0049-0172(84)90010-6. [DOI] [PubMed] [Google Scholar]
  18. Emslie-Smith A. M., Engel A. G. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol. 1990 Apr;27(4):343–356. doi: 10.1002/ana.410270402. [DOI] [PubMed] [Google Scholar]
  19. Engel A. G., Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol. 1984 Aug;16(2):209–215. doi: 10.1002/ana.410160207. [DOI] [PubMed] [Google Scholar]
  20. Fernández-Solá J., Grau J. M. Significado clínico de los valores séricos de creatincinasa y sus isoenzimas. Med Clin (Barc) 1990 May 12;94(18):708–710. [PubMed] [Google Scholar]
  21. Figarella-Branger D., Pellissier J. F., Bianco N., Devictor B., Toga M. Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product. Acta Neuropathol. 1990;79(5):528–536. doi: 10.1007/BF00296113. [DOI] [PubMed] [Google Scholar]
  22. Heckmatt J., Hasson N., Saunders C., Thompson N., Peters A. M., Cambridge G., Rose M., Hyde S. A., Dubowitz V. Cyclosporin in juvenile dermatomyositis. Lancet. 1989 May 13;1(8646):1063–1066. doi: 10.1016/s0140-6736(89)92456-2. [DOI] [PubMed] [Google Scholar]
  23. Hochberg M. C., Feldman D., Stevens M. B. Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum. 1986 Feb;15(3):168–178. doi: 10.1016/0049-0172(86)90014-4. [DOI] [PubMed] [Google Scholar]
  24. Horowitz M., McNeil J. D., Maddern G. J., Collins P. J., Shearman D. J. Abnormalities of gastric and esophageal emptying in polymyositis and dermatomyositis. Gastroenterology. 1986 Feb;90(2):434–439. doi: 10.1016/0016-5085(86)90944-3. [DOI] [PubMed] [Google Scholar]
  25. Hudgson P., Peter J. B. Inflammatory disorders of muscle. Classification. Clin Rheum Dis. 1984 Apr;10(1):3–8. [PubMed] [Google Scholar]
  26. Jacob H., Berkowitz D., McDonald E., Bernstein L. H., Beneventano T. The esophageal motility disorder of polymyositis. A prospective study. Arch Intern Med. 1983 Dec;143(12):2262–2264. [PubMed] [Google Scholar]
  27. Jongen P. J., Joosten E. M., Berden J. H., Ter Laak H. J. Cyclosporine therapy in chronic slowly progressive polymyositis--preliminary report of clinical results in three patients. Transplant Proc. 1988 Jun;20(3 Suppl 4):335–339. [PubMed] [Google Scholar]
  28. Karpati G., Pouliot Y., Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol. 1988 Jan;23(1):64–72. doi: 10.1002/ana.410230111. [DOI] [PubMed] [Google Scholar]
  29. Kasper C. S., White C. L., 3rd, Freeman R. G. Pathology and immunopathology of polymyositis/dermatomyositis. Clin Dermatol. 1988 Apr-Jun;6(2):64–75. doi: 10.1016/0738-081x(88)90050-8. [DOI] [PubMed] [Google Scholar]
  30. Kaufman L. D., Gruber B. L., Gerstman D. P., Kaell A. T. Preliminary observations on the role of magnetic resonance imaging for polymyositis and dermatomyositis. Ann Rheum Dis. 1987 Aug;46(8):569–572. doi: 10.1136/ard.46.8.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lakhanpal S., Bunch T. W., Ilstrup D. M., Melton L. J., 3rd Polymyositis-dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc. 1986 Aug;61(8):645–653. doi: 10.1016/s0025-6196(12)62030-8. [DOI] [PubMed] [Google Scholar]
  32. Lakhanpal S., Lie J. T., Conn D. L., Martin W. J., 2nd Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis. 1987 Jan;46(1):23–29. doi: 10.1136/ard.46.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lotz B. P., Engel A. G., Nishino H., Stevens J. C., Litchy W. J. Inclusion body myositis. Observations in 40 patients. Brain. 1989 Jun;112(Pt 3):727–747. doi: 10.1093/brain/112.3.727. [DOI] [PubMed] [Google Scholar]
  34. Manchul L. A., Jin A., Pritchard K. I., Tenenbaum J., Boyd N. F., Lee P., Germanson T., Gordon D. A. The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study. Arch Intern Med. 1985 Oct;145(10):1835–1839. [PubMed] [Google Scholar]
  35. Manta P., Kalfakis N., Vassilopoulos D. Evidence for seasonal variation in polymyositis. Neuroepidemiology. 1989;8(5):262–265. doi: 10.1159/000110192. [DOI] [PubMed] [Google Scholar]
  36. Mastaglia F. L., Ojeda V. J. Inflammatory myopathies: Part 1. Ann Neurol. 1985 Mar;17(3):215–227. doi: 10.1002/ana.410170302. [DOI] [PubMed] [Google Scholar]
  37. Oddis C. V., Medsger T. A. Current management of polymyositis and dermatomyositis. Drugs. 1989 Mar;37(3):382–390. doi: 10.2165/00003495-198937030-00007. [DOI] [PubMed] [Google Scholar]
  38. Pachman L. M. Juvenile dermatomyositis. Pediatr Clin North Am. 1986 Oct;33(5):1097–1117. doi: 10.1016/s0031-3955(16)36110-7. [DOI] [PubMed] [Google Scholar]
  39. Pestronk A., Adams R. N., Kuncl R. W., Drachman D. B., Clawson L. L., Cornblath D. R. Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders. Neurology. 1989 May;39(5):628–633. doi: 10.1212/wnl.39.5.628. [DOI] [PubMed] [Google Scholar]
  40. Plotz P. H., Dalakas M., Leff R. L., Love L. A., Miller F. W., Cronin M. E. Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med. 1989 Jul 15;111(2):143–157. doi: 10.7326/0003-4819-111-2-143. [DOI] [PubMed] [Google Scholar]
  41. Richardson J. B., Callen J. P. Dermatomyositis and malignancy. Med Clin North Am. 1989 Sep;73(5):1211–1220. doi: 10.1016/s0025-7125(16)30629-0. [DOI] [PubMed] [Google Scholar]
  42. Riggs J. E., Schochet S. S., Jr, Gutmann L., McComas C. F., Rogers J. S., 2nd Inclusion body myositis and chronic immune thrombocytopenia. Arch Neurol. 1984 Jan;41(1):93–95. doi: 10.1001/archneur.1984.04050130099033. [DOI] [PubMed] [Google Scholar]
  43. Schumacher H. R., Schimmer B., Gordon G. V., Bookspan M. A., Brogadir S., Dorwart B. B. Articular manifestations of polymyositis and dermatomyositis. Am J Med. 1979 Aug;67(2):287–292. doi: 10.1016/0002-9343(79)90404-2. [DOI] [PubMed] [Google Scholar]
  44. Serratrice G., Schiano A., Pellissier J. F., Pouget J. Etude de 135 cas de polymyosites. Rev Neurol (Paris) 1986;142(12):906–917. [PubMed] [Google Scholar]
  45. Stewart S. S., Ashizawa T., Dudley A. W., Jr, Goldberg J. W., Lidsky M. D. Cerebral vasculitis in relapsing polychondritis. Neurology. 1988 Jan;38(1):150–152. doi: 10.1212/wnl.38.1.150. [DOI] [PubMed] [Google Scholar]
  46. Tazelaar H. D., Viggiano R. W., Pickersgill J., Colby T. V. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis. 1990 Mar;141(3):727–733. doi: 10.1164/ajrccm/141.3.727. [DOI] [PubMed] [Google Scholar]
  47. Tymms K. E., Webb J. Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol. 1985 Dec;12(6):1140–1148. [PubMed] [Google Scholar]
  48. Urbano-Marquez A., Estruch R., Navarro-Lopez F., Grau J. M., Mont L., Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989 Feb 16;320(7):409–415. doi: 10.1056/NEJM198902163200701. [DOI] [PubMed] [Google Scholar]
  49. Urbano-Márquez A., Estruch R., Grau J. M., Grañena A., Martín-Ortega E., Palou J., Rozman C. Inflammatory myopathy associated with chronic graft-versus-host disease. Neurology. 1986 Aug;36(8):1091–1093. doi: 10.1212/wnl.36.8.1091. [DOI] [PubMed] [Google Scholar]
  50. Urbano-Márquez A., Grau Junyent J. M., Casademont Pou J., Pedro-Botet Montoya J. C., Serra Peñaranda A., Estruch R. Miopatía inflamatoria idiopática. Análisis de una serie de 30 casos. Med Clin (Barc) 1986 Mar 8;86(9):353–356. [PubMed] [Google Scholar]
  51. Walton J. The inflammatory myopathies. J R Soc Med. 1983 Dec;76(12):998–1010. doi: 10.1177/014107688307601205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yunis E. J., Samaha F. J. Inclusion body myositis. Lab Invest. 1971 Sep;25(3):240–248. [PubMed] [Google Scholar]
  53. Zabel P., Leimenstoll G., Gross W. L. Cyclosporin for acute dermatomyositis. Lancet. 1984 Feb 11;1(8372):343–343. doi: 10.1016/s0140-6736(84)90391-x. [DOI] [PubMed] [Google Scholar]
  54. al-Janadi M., Smith C. D., Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol. 1989 Dec;16(12):1592–1596. [PubMed] [Google Scholar]
  55. de Merieux P., Verity M. A., Clements P. J., Paulus H. E. Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis. Arthritis Rheum. 1983 Aug;26(8):961–968. doi: 10.1002/art.1780260804. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES